HighTower Advisors’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
99,613
-9,050
| -8% | -$30K | ﹤0.01% | 2834 |
|
|
2025
Q1 | $315K | Buy |
108,663
+29,027
| +36% | +$84.2K | ﹤0.01% | 2810 |
|
|
2024
Q4 | $284K | Sell |
79,636
-28,377
| -26% | -$101K | ﹤0.01% | 2909 |
|
|
2024
Q3 | $537K | Sell |
108,013
-200
| -0.2% | -$994 | ﹤0.01% | 2348 |
|
|
2024
Q2 | $282K | Buy |
+108,213
| New | +$282K | ﹤0.01% | 2746 |
|
|
2024
Q1 | – | Sell |
-130,805
| Closed | -$265K | – | 3306 |
|
|
2023
Q4 | $265K | Buy |
130,805
+500
| +0.4% | +$1.01K | ﹤0.01% | 2773 |
|
|
2023
Q3 | $199K | Hold |
130,305
| – | – | ﹤0.01% | 2903 |
|
|
2023
Q2 | $216K | Hold |
130,305
| – | – | ﹤0.01% | 2791 |
|
|
2023
Q1 | $148K | Hold |
130,305
| – | – | ﹤0.01% | 2823 |
|
|
2022
Q4 | $117K | Hold |
130,305
| – | – | ﹤0.01% | 2880 |
|
|
2022
Q3 | $152K | Buy |
+130,305
| New | +$152K | ﹤0.01% | 2648 |
|
|
2022
Q2 | – | Sell |
-130,305
| Closed | -$340K | – | 2994 |
|
|
2022
Q1 | $340K | Buy |
130,305
+1,500
| +1% | +$3.91K | ﹤0.01% | 2408 |
|
|
2021
Q4 | $501K | Buy |
128,805
+2,000
| +2% | +$7.78K | ﹤0.01% | 2144 |
|
|
2021
Q3 | $553K | Hold |
126,805
| – | – | ﹤0.01% | 1991 |
|
|
2021
Q2 | $504K | Buy |
126,805
+58,188
| +85% | +$231K | ﹤0.01% | 2040 |
|
|
2021
Q1 | $357K | Buy |
+68,617
| New | +$357K | ﹤0.01% | 2166 |
|